STAT Plus: Cleveland Clinic’s Nissen denies any communication with FDA about Amarin’s Vascepa
Drama, thy name is Amarin.
If you want to get a rise out of investors who have been following Amarin, the maker of the fish-oil-derived heart drug Vascepa, try mentioning the name of Cleveland Clinic cardiologist Dr. Steven Nissen.
Continue to STAT Plus to read the full story…
